AAAAAA

   
Results: 1-11 |
Results: 11

Authors: BOEZEMAN J RAYMAKERS R VIERWINDEN G LINSSEN P
Citation: J. Boezeman et al., AUTOMATIC-ANALYSIS OF GROWTH ONSET, GROWTH-RATE AND COLONY SIZE OF INDIVIDUAL BONE-MARROW PROGENITORS, Cytometry, 28(4), 1997, pp. 305-310

Authors: SMEETS M RAYMAKERS R VIERWINDEN G PENNINGS A VANDELOCHT L WESSELS H BOEZEMAN J DEWITTE T
Citation: M. Smeets et al., A LOW BUT FUNCTIONALLY SIGNIFICANT MDR1 EXPRESSION PROTECTS PRIMITIVEHEMATOPOIETIC PROGENITOR CELLS FROM ANTHRACYCLINE TOXICITY, British Journal of Haematology, 96(2), 1997, pp. 346-355

Authors: SMEETS MEP RAYMAKERS RAP VIERWINDEN G PENNINGS AHM BOEZEMAN J DEWITTE T
Citation: Mep. Smeets et al., IDARUBICIN DNA INTERCALATION IS INFLUENCED BY MRP, NOT PGP, Blood, 90(10), 1997, pp. 799-799

Authors: SMEETS MEP RAYMAKERS RAP VIERWINDEN G BOEZEMAN J DEWITTE T
Citation: Mep. Smeets et al., RHODAMINE DULL PROGENITORS ARE MORE FREQUENTLY FOUND IN CORD-BLOOD AND HAVE A HIGHER CLONOGENIC CAPACITY COMPARED TO BONE-MARROW AND PERIPHERAL-BLOOD, WITHOUT IMMUNOPHENOTYPICAL DIFFERENCES INCLUDING ADHESION MOLECULES, Blood, 88(10), 1996, pp. 421-421

Authors: VERBRUGGEN B NOVAKOVA I WESSELS H BOEZEMAN J VANDENBERG M MAUSERBUNSCHOTEN E
Citation: B. Verbruggen et al., THE NIJMEGEN MODIFICATION OF THE BETHESDA ASSAY FOR FACTOR-VIII-C INHIBITORS - IMPROVED SPECIFICITY AND RELIABILITY, Thrombosis and haemostasis, 73(2), 1995, pp. 247-251

Authors: VANDERLELY N MINDERMAN H WESSELS H HILLEGERS M LINSSEN P PENNINGS A BRONS P BOEZEMAN J DEWITTE T
Citation: N. Vanderlely et al., DETECTION OF INCORPORATED IODODEOXYURIDINE IN COLONIES BY IMMUNOPEROXIDASE STAINING - A NOVEL METHOD TO MEASURE THE PROPORTION OF CYCLING COLONY-FORMING CELLS, Experimental hematology, 23(3), 1995, pp. 236-243

Authors: RAYMAKERS R PREIJERS F BOEZEMAN J RUTTEN E DEWITTE T
Citation: R. Raymakers et al., PROGNOSTIC IMPLICATIONS OF BONE-MARROW CULTURING IN MYELODYSPLASTIC SYNDROME - A RETROSPECTIVE ANALYSIS, Leukemia & lymphoma, 14(1-2), 1994, pp. 111-120

Authors: MINDERMAN H LINSSEN P VANDERLELY N WESSELS J BOEZEMAN J DEWITTE T HAANEN C
Citation: H. Minderman et al., TOXICITY OF IDARUBICIN AND DOXORUBICIN TOWARDS NORMAL AND LEUKEMIC HUMAN BONE-MARROW PROGENITORS IN RELATION TO THEIR PROLIFERATIVE STATE, Leukemia, 8(3), 1994, pp. 382-387

Authors: RAYMAKERS R VIERWINDEN G PENNINGS A BOEZEMAN J WESSELS J DEWITTE T
Citation: R. Raymakers et al., CD34+ CELLS OF A MORE PRIMITIVE PHENOTYPE (CD13+ 33-) ARE DELAYED IN GROWTH INITIATION IN COMPARISON WITH MORE DIFFERENTIATED PROGENITOR CELLS (CD13+/33+)/, Experimental hematology, 22(8), 1994, pp. 755-755

Authors: DEWITTE T AWWAD B BOEZEMAN J SCHATTENBERG A MUUS P RAEMAEKERS J PREIJERS F STRIJCKMANS P HAANEN C
Citation: T. Dewitte et al., ROLE OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN ADOLESCENT OR ADULTPATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA IN FIRST REMISSION, Bone marrow transplantation, 14(5), 1994, pp. 767-774

Authors: GOVERDE G RAEMAEKERS J PENNINGS A BOGMAN J BOEZEMAN J WESSELS J DEWITTE T
Citation: G. Goverde et al., ANALYSIS OF CELL-CYCLE KINETICS WITH IN-VIVO IODODEOXYURIDINE IN IMMUNOPHENOTYPICALLY SELECTED CELLULAR SUBSETS OF B-CELL LYMPHOMAS, Blood, 82(10), 1993, pp. 10000132-10000132
Risultati: 1-11 |